The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome
dc.contributor.author | Santos, Ana Celly Souza dos | |
dc.contributor.author | Soares, Nayara Pereira | |
dc.contributor.author | Costa, Eduardo Caldas | |
dc.contributor.author | Sá, Joceline Cássia Ferrezini de | |
dc.contributor.author | Azevedo, George Dantas de | |
dc.contributor.author | Lemos, Telma Maria Araújo Moura | |
dc.date.accessioned | 2021-02-23T18:35:18Z | |
dc.date.available | 2021-02-23T18:35:18Z | |
dc.date.issued | 2015-11-06 | |
dc.description.resumo | Objective: to evaluate inflammatory markers and insulin resistance (IR) in women with and without polycystic ovary syndrome (PCOS), with different body mass index (BMI). Methods: tumor necrosis factor-alpha (TNF-a), interleukin-6 (IL-6) and C-reactive protein (CRP) were assessed in serum samples from 40 women in reproductive age. Patients were divided into four groups: I (non-eutrophic with PCOS, n¼12), II (non-eutrophic without PCOS, n¼10), III (eutrophic with PCOS, n¼8) and IV (eutrophic without PCOS, n¼10) being non-eutrophic, the overweight and obese women with BMI425 kg/m2 and eutrophic women with BMI524.9 kg/m2. Homeostatic model assessment (HOMA-IR) was calculated for evaluation of IR. Results: PCOS patients showed increased levels of CRP (p50.01) and HOMA-IR (p50.01). When divided by BMI, both non-eutrophic and eutrophic PCOS showed increased CRP levels (p50.01) and HOMA-IR (p50.01). There were no differences in TNF-a and IL-6 levels between groups. Conclusion: in the PCOS group, the levels of CRP and IR were elevated, compared to their counterparts, regardless of body mass | pt_BR |
dc.identifier.citation | SANTOS, Ana Celly Souza dos; SOARES, Nayara Pereira; COSTA, Eduardo Caldas; SÁ, Joceline Cássia Ferrezini de; AZEVEDO, George Dantas de; LEMOS, Telma Maria Araújo Moura. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome. Gynecological Endocrinology, [s. l.], v. 31, n. 3, p. 225-228, 6 nov. 2015. Disponível em: https://www.tandfonline.com/doi/abs/10.3109/09513590.2014.976546?journalCode=igye20. Acesso em: 02 jul. 2020. http://dx.doi.org/10.3109/09513590.2014.976546 | pt_BR |
dc.identifier.doi | 10.3109/09513590.2014.976546 | |
dc.identifier.issn | 0951-3590 | |
dc.identifier.issn | 1473-0766 | |
dc.identifier.uri | https://repositorio.ufrn.br/handle/123456789/31611 | |
dc.language | en | pt_BR |
dc.publisher | Taylor and Francis | pt_BR |
dc.rights | Attribution 3.0 Brazil | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/br/ | * |
dc.subject | Cytokines | pt_BR |
dc.subject | Inflammation | pt_BR |
dc.subject | Insulin resistance | pt_BR |
dc.subject | Nutritional status | pt_BR |
dc.subject | Obesity | pt_BR |
dc.subject | Ovary | pt_BR |
dc.subject | Polycystic ovary syndrome | pt_BR |
dc.title | The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome | pt_BR |
dc.type | article | pt_BR |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- ImpactBodyMass_Azevedo_2015.pdf
- Tamanho:
- 156.98 KB
- Formato:
- Adobe Portable Document Format
Carregando...
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.45 KB
- Formato:
- Item-specific license agreed upon to submission
Nenhuma Miniatura disponível